Cargando…
Quantitative super-resolution imaging of pathological aggregates reveals distinct toxicity profiles in different synucleinopathies
Protein aggregation is a hallmark of major neurodegenerative disorders. Increasing data suggest that smaller aggregates cause higher toxic response than filamentous aggregates (fibrils). However, the size of small aggregates has challenged their detection within biologically relevant environments. H...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9573094/ https://www.ncbi.nlm.nih.gov/pubmed/36206368 http://dx.doi.org/10.1073/pnas.2205591119 |
_version_ | 1784810782035279872 |
---|---|
author | Morten, Michael J. Sirvio, Liina Rupawala, Huzefa Mee Hayes, Emma Franco, Aitor Radulescu, Carola Ying, Liming Barnes, Samuel J. Muga, Arturo Ye, Yu |
author_facet | Morten, Michael J. Sirvio, Liina Rupawala, Huzefa Mee Hayes, Emma Franco, Aitor Radulescu, Carola Ying, Liming Barnes, Samuel J. Muga, Arturo Ye, Yu |
author_sort | Morten, Michael J. |
collection | PubMed |
description | Protein aggregation is a hallmark of major neurodegenerative disorders. Increasing data suggest that smaller aggregates cause higher toxic response than filamentous aggregates (fibrils). However, the size of small aggregates has challenged their detection within biologically relevant environments. Here, we report approaches to quantitatively super-resolve aggregates in live cells and ex vivo brain tissues. We show that Amytracker 630 (AT630), a commercial aggregate-activated fluorophore, has outstanding photophysical properties that enable super-resolution imaging of α-synuclein, tau, and amyloid-β aggregates, achieving ∼4 nm precision. Applying AT630 to App(NL-G-F) mouse brain tissues or aggregates extracted from a Parkinson’s disease donor, we demonstrate excellent agreement with antibodies specific for amyloid-β or α-synuclein, respectively, confirming the specificity of AT630. Subsequently, we use AT630 to reveal a linear relationship between α-synuclein aggregate size and cellular toxicity and discovered that aggregates smaller than 450 ± 60 nm (aggregate(450nm)) readily penetrated the plasma membrane. We determine aggregate(450nm) concentrations in six Parkinson’s disease and dementia with Lewy bodies donor samples and show that aggregates in different synucleinopathies demonstrate distinct potency in toxicity. We further show that cell-penetrating aggregates are surrounded by proteasomes, which assemble into foci to gradually process aggregates. Our results suggest that the plasma membrane effectively filters out fibrils but is vulnerable to penetration by aggregates of 450 ± 60 nm. Together, our findings present an exciting strategy to determine specificity of aggregate toxicity within heterogeneous samples. Our approach to quantitatively measure these toxic aggregates in biological environments opens possibilities to molecular examinations of disease mechanisms under physiological conditions. |
format | Online Article Text |
id | pubmed-9573094 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | National Academy of Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-95730942022-10-17 Quantitative super-resolution imaging of pathological aggregates reveals distinct toxicity profiles in different synucleinopathies Morten, Michael J. Sirvio, Liina Rupawala, Huzefa Mee Hayes, Emma Franco, Aitor Radulescu, Carola Ying, Liming Barnes, Samuel J. Muga, Arturo Ye, Yu Proc Natl Acad Sci U S A Biological Sciences Protein aggregation is a hallmark of major neurodegenerative disorders. Increasing data suggest that smaller aggregates cause higher toxic response than filamentous aggregates (fibrils). However, the size of small aggregates has challenged their detection within biologically relevant environments. Here, we report approaches to quantitatively super-resolve aggregates in live cells and ex vivo brain tissues. We show that Amytracker 630 (AT630), a commercial aggregate-activated fluorophore, has outstanding photophysical properties that enable super-resolution imaging of α-synuclein, tau, and amyloid-β aggregates, achieving ∼4 nm precision. Applying AT630 to App(NL-G-F) mouse brain tissues or aggregates extracted from a Parkinson’s disease donor, we demonstrate excellent agreement with antibodies specific for amyloid-β or α-synuclein, respectively, confirming the specificity of AT630. Subsequently, we use AT630 to reveal a linear relationship between α-synuclein aggregate size and cellular toxicity and discovered that aggregates smaller than 450 ± 60 nm (aggregate(450nm)) readily penetrated the plasma membrane. We determine aggregate(450nm) concentrations in six Parkinson’s disease and dementia with Lewy bodies donor samples and show that aggregates in different synucleinopathies demonstrate distinct potency in toxicity. We further show that cell-penetrating aggregates are surrounded by proteasomes, which assemble into foci to gradually process aggregates. Our results suggest that the plasma membrane effectively filters out fibrils but is vulnerable to penetration by aggregates of 450 ± 60 nm. Together, our findings present an exciting strategy to determine specificity of aggregate toxicity within heterogeneous samples. Our approach to quantitatively measure these toxic aggregates in biological environments opens possibilities to molecular examinations of disease mechanisms under physiological conditions. National Academy of Sciences 2022-10-07 2022-10-11 /pmc/articles/PMC9573094/ /pubmed/36206368 http://dx.doi.org/10.1073/pnas.2205591119 Text en Copyright © 2022 the Author(s). Published by PNAS. https://creativecommons.org/licenses/by/4.0/This open access article is distributed under Creative Commons Attribution License 4.0 (CC BY) (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Biological Sciences Morten, Michael J. Sirvio, Liina Rupawala, Huzefa Mee Hayes, Emma Franco, Aitor Radulescu, Carola Ying, Liming Barnes, Samuel J. Muga, Arturo Ye, Yu Quantitative super-resolution imaging of pathological aggregates reveals distinct toxicity profiles in different synucleinopathies |
title | Quantitative super-resolution imaging of pathological aggregates reveals distinct toxicity profiles in different synucleinopathies |
title_full | Quantitative super-resolution imaging of pathological aggregates reveals distinct toxicity profiles in different synucleinopathies |
title_fullStr | Quantitative super-resolution imaging of pathological aggregates reveals distinct toxicity profiles in different synucleinopathies |
title_full_unstemmed | Quantitative super-resolution imaging of pathological aggregates reveals distinct toxicity profiles in different synucleinopathies |
title_short | Quantitative super-resolution imaging of pathological aggregates reveals distinct toxicity profiles in different synucleinopathies |
title_sort | quantitative super-resolution imaging of pathological aggregates reveals distinct toxicity profiles in different synucleinopathies |
topic | Biological Sciences |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9573094/ https://www.ncbi.nlm.nih.gov/pubmed/36206368 http://dx.doi.org/10.1073/pnas.2205591119 |
work_keys_str_mv | AT mortenmichaelj quantitativesuperresolutionimagingofpathologicalaggregatesrevealsdistincttoxicityprofilesindifferentsynucleinopathies AT sirvioliina quantitativesuperresolutionimagingofpathologicalaggregatesrevealsdistincttoxicityprofilesindifferentsynucleinopathies AT rupawalahuzefa quantitativesuperresolutionimagingofpathologicalaggregatesrevealsdistincttoxicityprofilesindifferentsynucleinopathies AT meehayesemma quantitativesuperresolutionimagingofpathologicalaggregatesrevealsdistincttoxicityprofilesindifferentsynucleinopathies AT francoaitor quantitativesuperresolutionimagingofpathologicalaggregatesrevealsdistincttoxicityprofilesindifferentsynucleinopathies AT radulescucarola quantitativesuperresolutionimagingofpathologicalaggregatesrevealsdistincttoxicityprofilesindifferentsynucleinopathies AT yingliming quantitativesuperresolutionimagingofpathologicalaggregatesrevealsdistincttoxicityprofilesindifferentsynucleinopathies AT barnessamuelj quantitativesuperresolutionimagingofpathologicalaggregatesrevealsdistincttoxicityprofilesindifferentsynucleinopathies AT mugaarturo quantitativesuperresolutionimagingofpathologicalaggregatesrevealsdistincttoxicityprofilesindifferentsynucleinopathies AT yeyu quantitativesuperresolutionimagingofpathologicalaggregatesrevealsdistincttoxicityprofilesindifferentsynucleinopathies |